Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 538 entries
Sorted by: Best Match Show Resources per page
Bis(silylenyl)-substituted ferrocene-stabilized η.

Dalton transactions (Cambridge, England : 2003)

Luecke MP, Porwal D, Kostenko A, Zhou YP, Yao S, Keck M, Limberg C, Oestreich M, Driess M.
PMID: 28967014
Dalton Trans. 2017 Dec 21;46(47):16412-16418. doi: 10.1039/c7dt03301j. Epub 2017 Oct 02.

Reaction of FeX

Silylene-Nickel Promoted Cleavage of B-O Bonds: From Catechol Borane to the Hydroborylene Ligand.

Angewandte Chemie (International ed. in English)

Hadlington TJ, Szilvási T, Driess M.
PMID: 28481013
Angew Chem Int Ed Engl. 2017 Jun 19;56(26):7470-7474. doi: 10.1002/anie.201702772. Epub 2017 May 08.

The first 16 valence electron [bis(NHC)](silylene)Ni

Nitrous Oxide as a Hydrogen Acceptor for the Dehydrogenative Coupling of Alcohols.

Angewandte Chemie (International ed. in English)

Gianetti TL, Annen SP, Santiso-Quinones G, Reiher M, Driess M, Grützmacher H.
PMID: 26693955
Angew Chem Int Ed Engl. 2016 Jan 26;55(5):1854-8. doi: 10.1002/anie.201509288. Epub 2015 Dec 22.

The oxidation of alcohols with N2O as the hydrogen acceptor was achieved with low catalyst loadings of a rhodium complex that features a cooperative bis(olefin)amido ligand under mild conditions. Two different methods enable the formation of either the corresponding...

Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen

Friess E.
PMID: 28354762
Wilhelm Roux Arch Entwickl Mech Org. 1933 Jun;129(2):255-355. doi: 10.1007/BF00573906.

No abstract available.

Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers.

Gastrointestinal tumors

Reim D, Friess H.
PMID: 27403411
Gastrointest Tumors. 2016 May;2(4):166-77. doi: 10.1159/000442907. Epub 2016 Jan 08.

BACKGROUND: Patients undergoing treatment for esophagogastric or esophageal cancer are exposed to a considerably high risk of malnutrition due to early obstruction of the gastrointestinal passage. Presently most of the patients undergo modern multimodal therapies which require chemoradiation or...

Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease.

Frontiers in behavioral neuroscience

El Massioui N, Lamirault C, Yagüe S, Adjeroud N, Garces D, Maillard A, Tallot L, Yu-Taeger L, Riess O, Allain P, Nguyen HP, von Hörsten S, Doyère V.
PMID: 27833538
Front Behav Neurosci. 2016 Oct 26;10:204. doi: 10.3389/fnbeh.2016.00204. eCollection 2016.

Cognitive deficits associated with Huntington disease (HD) are generally dominated by executive function disorders often associated with disinhibition and impulsivity/compulsivity. Few studies have directly examined symptoms and consequences of behavioral disinhibition in HD and its relation with decision-making. To...

Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience.

HPB surgery : a world journal of hepatic, pancreatic and biliary surgery

Kleeff J, Michalski C, Kong B, Erkan M, Roth S, Siveke J, Friess H, Esposito I.
PMID: 25873753
HPB Surg. 2015;2015:847837. doi: 10.1155/2015/847837. Epub 2015 Mar 19.

Introduction. The management of cystic pancreatic lesions has changed in recent years as a result of increasing knowledge of their biological behaviour, better diagnostic options, and international guidelines. Methods. Retrospective analysis of a cohort of 86 patients operated for...

The calpain-suppressing effects of olesoxime in Huntington's disease.

Rare diseases (Austin, Tex.)

Weber JJ, Ortiz Rios MM, Riess O, Clemens LE, Nguyen HP.
PMID: 27141414
Rare Dis. 2016 Apr 06;4(1):e1153778. doi: 10.1080/21675511.2016.1153778. eCollection 2016.

Olesoxime, a small molecule drug candidate, has recently attracted attention due to its significant beneficial effects in models of several neurodegenerative disorders including Huntington's disease. Olesoxime's neuroprotective effects have been assumed to be conveyed through a direct, positive influence...

A donor-stabilized zwitterionic "half-parent" phosphasilene and its unusual reactivity towards small molecules.

Chemistry (Weinheim an der Bergstrasse, Germany)

Hansen K, Szilvási T, Blom B, Irran E, Driess M.
PMID: 24436015
Chemistry. 2014 Feb 10;20(7):1947-56. doi: 10.1002/chem.201303906. Epub 2014 Jan 16.

The stabilization of the labile, zwitterionic "half-parent" phosphasilene 4 L'Si=PH (L'=CH[(C=CH2)CMe(NAr)2]; Ar=2,6-iPr2C6H3) could now be accomplished by coordination with two different donor ligands (4-dimethylaminopyridine (DMAP) and 1,3,4,5-tetramethylimidazol-2-ylidene), affording the adducts 8 and 9, respectively. The DMAP-stabilized zwitterionic "half-parent" phosphasilene...

An elusive hydridoaluminum(I) complex for facile C-H and C-O bond activation of ethers and access to its isolable hydridogallium(I) analogue: syntheses, structures, and theoretical studies.

Journal of the American Chemical Society

Tan G, Szilvási T, Inoue S, Blom B, Driess M.
PMID: 24940870
J Am Chem Soc. 2014 Jul 09;136(27):9732-42. doi: 10.1021/ja504448v. Epub 2014 Jun 26.

The reaction of AlBr3 with 1 molar equiv of the chelating bis(N-heterocyclic carbene) ligand bis(N-Dipp-imidazole-2-ylidene)methylene (bisNHC, 1) affords [(bisNHC)AlBr2](+)Br(-) (2) as an ion pair in high yield, representing the first example of a bisNHC-Al(III) complex. Debromination of the latter...

Improved reconstruction of phase-stepping data for Talbot-Lau x-ray imaging.

Journal of medical imaging (Bellingham, Wash.)

Kaeppler S, Rieger J, Pelzer G, Horn F, Michel T, Maier A, Anton G, Riess C.
PMID: 28894764
J Med Imaging (Bellingham). 2017 Jul;4(3):034005. doi: 10.1117/1.JMI.4.3.034005. Epub 2017 Sep 05.

Grating-based Talbot-Lau x-ray interferometry is a popular method for measuring absorption, phase shift, and small-angle scattering. The standard acquisition method for this modality is phase stepping, where the Talbot pattern is reconstructed from multiple images acquired at different grating...

Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review.

World journal of gastrointestinal oncology

Riess H, Habbel P, Jühling A, Sinn M, Pelzer U.
PMID: 26989461
World J Gastrointest Oncol. 2016 Mar 15;8(3):258-70. doi: 10.4251/wjgo.v8.i3.258.

Venous thromboembolism event (VTE) is a common and morbid complication in cancer patients. Patients with gastrointestinal cancers often suffer from symptomatic or incidental splanchnic vein thrombosis, impaired liver function and/or thrombocytopenia. These characteristics require a thorough risk/benefit evaluation for...

Showing 1 to 12 of 538 entries